ICNAF
Stock ticker:
OTC
OTC
Intraday data for
Jan 27, closing price
Price
$0.15
Change
$0.00 (0.00%)
Capitalization
$33.6m
ICNAF Price Prediction, Icanic Brands CO AI Recommendations Industry @PharmaceuticalsOther
Stock ticker: OTC
ICNAF
AS OF
Jan 27, closing price
Price
$0.15
Change
$0.00 (0.00%)
Capitalization
$33.6m
ICNAF Price Prediction, Icanic Brands CO AI Recommendations
Stock market charts, price targets, analyst ratings and a financial calendar
Industry @PharmaceuticalsOtherA.I.dvisor published
ICNAF Commentaries and news forecasts
4:00 PM EST Jan 27
1W
1M
1Q
6M
1Y
5Y
ICNAF (Icanic Brands CO): Weekly Commentary
Please wait a moment while the chart loads...
An error occurred while loading prices!
AI Screener Basics
AI Screener FA & TA
Forecasts, Signals and Predictions about ICNAF (Icanic Brands CO)
| Technical Analysis | # Of Indicators | Avg. Odds |
|---|---|---|
| Bullish trend | | |
| Bearish trend | | |
| Bearish trend | | |
| Bullish trend | |
| Fundamental Analysis | (1 - best, 100 - worst) |
|---|
A.I.dvisor published
a Summary for ICNAF with price predictions.
4:00 PM EST Jan 25
ICNAF in -16.04% downward trend, sliding for three consecutive days on January 24, 2022
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ICNAF declined for three days, in
Current price $0.15 crossed the support line at $0.23 and is trading between $0.23 support and $0.10 support lines. Throughout the month of 12/22/21 - 01/25/22, the price experienced a -25% Downtrend. During the week of 01/18/22 - 01/25/22, the stock fell -10%.
Technical Analysis, Outlook, Fundamental Analysis READ MORE...
A.I.dvisor
published General Information
General Information
Profile
Fundamentals
Details
| Address | 789 West Pender Street, Vancouver, BC, V6C 1H2 |
| Phone | +1 604 687-2038 |
| Web | https://www.icaninc.com |
ICNAF
Select Stock attributes to show
| Capitalization | 33.6M |
| P/E Ratio | N/A |
| Risk (Beta) | 0.99 |
| Dividend Yield | N/A |
| Total Cash | 2.553M |
| Total Cash/Share | 0.01 |
| Total Debt | 1.688M |
| Total Debt/Equity | N/A |
| Projected Growth (PEG Ratio) | N/A |
| Revenue/Share (as % of the share price) | 0% |
| Revenue | 11.2M |
| ROE | N/A |
| Book Value | 66.8M |
| P/B Ratio | 0.66 |
| Cash Flow | N/A |
| Earnings | -0.024 |
| Average Daily Volume YTD | N/A |
| Common Shares Outstanding - Security Level | 83.7M |
| Current Ratio | 4.98 |
| Current Revenue Per Employee | N/A |
| Dividends Per Share - Security | N/A |
| EBITDA | -1,964,741 |
| Float | N/A |
| Float - Current | N/A |
| Gross Income Margin | 48.09 |
| Revenue To Assets | -3.83 |
| Shares Held By Institutions | 0 |
| Shares Outstanding - Current | N/A |
| Total Liabilities | 3.365M |
| Total Volume MTD | N/A |
| Value | Under |
| Gain YTD | -8.761 |
| Group | Domestic Stock Funds |
| Category | Pharmaceuticals |
| Total Expense Ratio | |
| Min. Initial Investment | 0.00 USD |
| Fund Existence | a few seconds ago |
| Turnover | |
| Front Load | |
| Net Assets | 0.00 USD |
| Manager Tenure |
| Group | Domestic Stock Funds | |
| Category | Pharmaceuticals | |
| Capitalization | 33.64m USD | |
| P/E Ratio | N/A | |
| Total Cash | 2.55m USD | |
| Projected Growth | N/A | |
| Total Debt | 1.69m USD | |
| Revenue | 11.15m USD | |
| Risk (Beta) | 0.99 | |
| Dividend Yield | N/A | |
| Total Cash/Share | 0.01 | |
| Total Debt/Equity | N/A | |
| Revenue/Share | 0.00USD | as % of share price |
| Group | Domestic Stock Funds |
| Category | Pharmaceuticals |
| Net Assets | 0.00 USD |
| Fund Existence | a few seconds ago |
| Turnover | |
| Capitalization | |
| Yield | |
| Total Expense Ratio | |
| Investment Style | |
| Risk (Beta) |
| Group | Domestic Stock Funds |
| Category | Pharmaceuticals |
| Market Capitalization | 0.00 USD |
| Volume | 0.00 USD |
A.I.dvisor
published a Pattern (end of day)
Interesting Tickers